Global Scleroderma Therapeutics Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

Segmented by Drug Class;

Immunosuppressors, Phosphodiesterase 5 Inhibitors - PHA, Endothelin Receptor Antagonists, Prostacyclin Analogues, Calcium Channel Blockers, Analgesics and Others.

Segmented by Indication;

Systemic and Localized.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2018 - 2028).
Report ID: Rn160278952 Published Date: April, 2022 Updated Date: May, 2022

Introduction

Global Scleroderma Therapeutics Market (USD Million), 2018 - 2028

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2018 - 2028
2018 102.0
2019 112.1
2020 128.4
2021 141.1
2022 145.6
2023 154.2
2024 179.9
2025 192.1
2026 195.1
2027 199.2
2028 214.1

In the year 2021, the Global Scleroderma Therapeutics Market was valued at USD 1,908.51 million. The size of this market is expected to increase to USD 2,739.64 million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of 5.3%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drug Class
    2. Market Snapshot, By Indication
    3. Market Snapshot, By Region
    4. Market Opportunity Map
  4. Global Scleroderma Therapeutics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Lack of curative therapies attract new players
        2. Growing prevalence of scleroderma therapeutics
        3. Developed regions present major opportunity markets
        4. Expanding pharmaceutical pipeline
      2. Restraints
        1. Lack of well-defined regulatory and reimbursement framework impedes growth in developing regions
        2. Reimbursement uncertainties in developed regions pose obstacles
      3. Opportunities
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Scleroderma Therapeutics Market, By Drug Class, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Immunosuppressors
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Phosphodiesterase 5 Inhibitors - PHA
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        3. Endothelin Receptor Antagonists
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        4. Prostacyclin Analogues
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        5. Calcium Channel Blockers
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        6. Analgesics
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        7. Others
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    2. Global Scleroderma Therapeutics Market, By Indication, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Systemic
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Localized
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    3. Global Scleroderma Therapeutics Market, By Geography, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
        4. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
        5. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2028 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. F. Hoffman La Roche
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Boehringer Ingelheim International GmbH
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Bristol-Myers Squibb Company
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. CELGENE CORPORATION
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. arGentis Pharmaceuticals, Llc
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. Prometic Life Sciences Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      7. Akashi Therapeutics
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      8. Kadmon Holdings, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      9. Emerald Health Pharmaceuticals
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      10. Cytori Therapeutics Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare Pharmaceuticals & Therapeutics Sclerotherapy
Global Sclerotherapy Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Sclerotherapy Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Medical Devices Sex Toys
Global Sex Toys Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Sex Toys Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Biotechnology Short-read Sequencing
Global Short-read Sequencing Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Short-read Sequencing Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare In Vitro Diagnostics Sickle Cell Anemia Testing & Screening
Global Sickle Cell Anemia Testing & Screening Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Sickle Cell Anemia Testing & Screening Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...